Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Abbosh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
British Journal of Haematology|December 1, 1975
Plasma heparin levels after low dose subcutaneous heparin in patients undergoing hip replacementM Brozović, Y Stirling, J Abbosh
Postgraduate Medical Journal|January 1, 1976
The effect of intensive immunosuppression on the in vitro activity of lymphocytes from multiple sclerosis patientsS C Knight, J Abbosh, E M Lance
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levelsV E Jones, E M Lance, J Abbosh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 3, 1999
Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patientsJ Abbosh, J A Anderson, A B Levine, et al.
Postgraduate Medical Journal|January 1, 1976
Toleracne to equine IgG after immunosuppression in patients with multiple sclerosisV E Jones, E M Lance, J Abbosh, et al.
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitroS C Knight, E M Lance, J Abbosh, et al.
Neurology|May 1, 1975
Proceedings: Intensive immunosuppression in multiple sclerosisE M Lance, J Abbosh, M Kremer, et al.
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical responseE M Lance, M Kremer, J Abbosh, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|December 1, 1975
Plasma heparin levels after low dose subcutaneous heparin in patients undergoing hip replacementM Brozović, Y Stirling, J Abbosh
Postgraduate Medical Journal|January 1, 1976
The effect of intensive immunosuppression on the in vitro activity of lymphocytes from multiple sclerosis patientsS C Knight, J Abbosh, E M Lance
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levelsV E Jones, E M Lance, J Abbosh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 3, 1999
Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patientsJ Abbosh, J A Anderson, A B Levine, et al.
Postgraduate Medical Journal|January 1, 1976
Toleracne to equine IgG after immunosuppression in patients with multiple sclerosisV E Jones, E M Lance, J Abbosh, et al.
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitroS C Knight, E M Lance, J Abbosh, et al.
Neurology|May 1, 1975
Proceedings: Intensive immunosuppression in multiple sclerosisE M Lance, J Abbosh, M Kremer, et al.
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical responseE M Lance, M Kremer, J Abbosh, et al.
Pageof 1